Navigation Links
U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant
Date:5/15/2009

ALBANY, N.Y., May 15 /PRNewswire/ -- Valeo Pharma announced today a new study recently published that demonstrated the efficacy and safety of Hydrosal(R), a novel high strength topical antiperspirant with 15% aluminum chloride and 2% salicylic acid in proprietary gel base for patients with moderate-to-severe hyperhidrosis (excessive sweating).

The study, conducted by Katherine Flanagan, MD and Dee Anna Glaser, MD at the Department of Dermatology at Saint Louis University School of Medicine, was published in the May issue of the Journal of Drugs in Dermatology (JDD). Of the thirty patients who were enrolled, 43% had tried high-strength antiperspirants previously. Patients were given Hydrosal and monitored at 4 and 12 weeks for efficacy and tolerability. They were instructed to apply a small amount of the gel at bedtime for seven days and twice per week or as tolerated thereafter.

Overall, 70% of participants demonstrated significant improvement with satisfaction of treatment and Hydrosal was well-tolerated with minimal side effects. Patients who had previously failed other high-strength antiperspirants also reported similar success. They also experienced significant improvements in quality of life including improvement in social and professional situations.

"The key to Hydrosal's effectiveness is the gel base -- it is unique and helps balance high efficacy and tolerability for patients with moderate to severe hyperhidrosis. Valeo is extremely pleased that these results have shown a significant improvement in the quality of life for these patients, so they can enjoy activities more and not have to worry about their excessive sweating," stated Steve Saviuk, President of Valeo Pharma.

To learn more about Hydrosal Professional, please visit www.hydrosalpro.com or contact Valeo Pharma at 866 694-0150. <
'/>"/>

SOURCE Valeo Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Pricing Healthcare announces it will ... patient receiving care at St. George Surgical Center ... be performed by July 15th, 2015, and the patient must ... front and forego the filing of insurance claims). , The ... year, and it devastates more and more individuals and families. ...
(Date:5/4/2015)... 2015 San Diego Fertility Center ... their brand new, 13,700 square foot facility scheduled to ... will not only provide fertility treatment and services for ... community and educational events to a number of local ... next door to their current Carmel Valley/Del Mar location ...
(Date:5/4/2015)... 04, 2015 Sheltering Arms announced that ... Hale House. The Mother Hale Learning Center meets a ... Childhood Education. Sheltering Arms will begin operating the site ... served by the center. , Opened in 2006, the ... weeks to five years, many of whom come from ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Dr. Benjamin ... Georgia proudly offers the latest non-surgical double-chin eliminator. ... facial plastic surgeon in Atlanta to offer Kybella ... to be injected specifically under the chin, promising to ... , Before Kybella, patients who sought immediate solutions for ...
(Date:5/4/2015)... New West Medicare is excited to announce ... manage outpatient advanced imaging services for its members. Care ... members are provided the right test at the right ... New West Medicare’s physicians and hospitals, Care to Care ... imaging and provide an objective basis for informed evidence-based ...
Breaking Medicine News(10 mins):Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... a fair distribution of bird flu vaccines, the World ... stockpile of vaccines// for developing countries. ,The global ... fight against avian influenza, WHO director general Margaret Chan ... ,Chan met President Susilo Bambang Yudhoyono Wednesday ...
... one million children under the age of five lose ... ,Considering the fact that these deaths are ... vaccine that addresses seven different strains of pneumococcal diseases ... ,Pneumococcal diseases, which affect the lungs, brain and the ...
... older population may soon be facing a medical care crisis ... rapidly//, say researchers at the University of Cincinnati. ... be more than 70 million people over the age of ... data collected over the last decade, the number of certified ...
... breast cancer who are treated with both chemotherapy ... patients who receive only tamoxifen//. But a combination ... ovaries from functioning—did not show any additional benefits, ... ,Survival rates improve for patients with ...
... Mediterranean diet could help protect children from respiratory allergies and ... and Spanish researchers assessed the diet and health of almost ... conditions are rare. ,Crete is the largest ... Mediterranean Sea. ,Researchers found those children reared on ...
... drugs during a recent influenza B epidemic in Japan ... the drugs//, according to a study. ,Two ... of drugs known as neuraminidase inhibitors, have been effective ... documented evidence of the emergence of oseltamivir-resistant type A ...
Cached Medicine News:Health News:Number of Students Taking Up Geriatric Medicine on the Decline 2Health News:Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients 2Health News:Fruit and Vegetable Diet 'could Prevent Asthma' 2Health News:Study Suggests Some Drug Resistance to Influenza B Medications 2
(Date:5/4/2015)... 4, 2015 Henry Schein, Inc. (NASDAQ: ... products and services to office-based dental, animal health and ... quarter ended March 28, 2015. Net sales ... an increase of 1.4% compared with the first quarter ... currencies and a 6.0% decline related to foreign currency ...
(Date:5/4/2015)...  Verus Healthcare, Inc. recently completed its third year ... in 2012.  Since that original acquisition, the Company has ... (DME) industry by 1,000%.  Verus Healthcare now services approximately ... and processes nearly 14,000 new orders per month. ... the systems and processes weren,t in place to scale," ...
(Date:5/4/2015)...  NeuroSigma ® , Inc. (NeuroSigma), a California ... animal study of its Thin Film Nitinol (TFN) flow diverter ... researchers at the 53 rd Annual Meeting of the ... . A copy of the study abstract can be accessed ... at Mayo Clinic was primarily funded through a Small Business ...
Breaking Medicine Technology:Henry Schein Reports Record First Quarter Results 2Henry Schein Reports Record First Quarter Results 3Henry Schein Reports Record First Quarter Results 4Henry Schein Reports Record First Quarter Results 5Henry Schein Reports Record First Quarter Results 6Henry Schein Reports Record First Quarter Results 7Henry Schein Reports Record First Quarter Results 8Henry Schein Reports Record First Quarter Results 9Henry Schein Reports Record First Quarter Results 10Henry Schein Reports Record First Quarter Results 11Henry Schein Reports Record First Quarter Results 12Henry Schein Reports Record First Quarter Results 13Henry Schein Reports Record First Quarter Results 14Henry Schein Reports Record First Quarter Results 15Henry Schein Reports Record First Quarter Results 16Henry Schein Reports Record First Quarter Results 17Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 3NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 4
... BD (Becton, Dickinson and Company) (NYSE: BDX ... revenues of $2.051 billion for the fourth fiscal quarter ended ... the prior-year period, or 4.0 percent on a foreign currency-neutral ... September 30, 2011, BD reported revenues of $7.829 billion, representing ...
... NEW YORK, Nov. 1, 2011 Keryx Biopharmaceuticals, Inc. ... on the acquisition, development and commercialization of medically important ... disease, today announced that a conference call will be ... EDT to discuss results for the third quarter ended ...
Cached Medicine Technology:BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 2BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 3BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 4BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 5BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 6BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 7BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 8BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 9BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 10BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 11BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 12BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 13Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: